Gubra AS's total inventories for the quarter that ended in Dec. 2025 was kr0 Mil. Gubra AS's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was kr0 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Gubra AS's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was kr57.27.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Gubra AS's Days Inventory for the
six
months ended in Dec. 2025 was 0.00.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gubra AS's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.00.
Gubra AS (CHIX:GUBRAc) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Gubra AS's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gubra AS's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Gubra AS Total Inventories Related Terms
Gubra AS Total Inventories Historical Data
* Premium members only.
The historical data trend for Gubra AS's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Gubra AS (CHIX:GUBRAC) has a Total Inventories of kr0 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Gubra AS and its competitors.
Is Gubra AS's Total Inventories too high?
Gubra AS's current Total Inventories is kr0 Mil. Overall, Gubra AS has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Total Inventories compare to VRTX and REGN?
Gubra AS's Total Inventories of kr0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Gubra AS and its competitors. Gubra AS's current Total Inventories is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Gubra AS (CHIX:GUBRAC) has a current Total Inventories of kr0 Mil. The stock's GF Value™ is kr2,972.88, compared to a current price of kr354.50 — trading 88.1% below its estimated fair value. The current Total Inventories is kr0 Mil. Gubra AS's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Gubra AS (CHIX:GUBRAC), the current Total Inventories is kr0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gubra AS (CHIX:GUBRAC) Overvalued in 2026?
Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued.
The current stock price of kr354.50 is trading 88.1% below its estimated GF Value™ of kr2,972.88.
Key valuation signals for CHIX:GUBRAC:
Total Inventories: kr0 Mil
GF Value™: kr2,972.88 vs. price of kr354.50 (88.1% below fair value)
No single metric tells the full story. See the CHIX:GUBRAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score
Get the complete analysis for CHIX:GUBRAC
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:GUBRAC has been successfully added to your 
